Bloomberg reports that drug wholesaler McKesson Corp. will likely settle damage claims of as much as $15 billion for inflating prices on prescription drugs paid by private health-benefit plans and individuals. McKesson has more than $100 billion in annual revenues. The drug distributor has denied the claims made in the lawsuit. The Bloomberg article offers good background on the case. Read it here.
Related articles from MDM:
McKesson May Face Treble Damages in Class Action
Judge Certified Class-Action Against McKesson in Pricing Battle
Report: McKesson Likely to Settle Claims in Pricing Case
Bloomberg reports that drug wholesaler McKesson Corp. will likely settle damage claims of as much as $15 billion for inflating prices on prescription drugs paid by private health-benefit plans and individuals. McKesson has more than $100 billion in annual revenues. The drug distributor has denied the claims made in the lawsuit. The Bloomberg article offers good background on the case. Read it here.
Related articles from MDM:
McKesson May Face Treble Damages in Class Action ...
Related articles from MDM:
McKesson May Face Treble Damages in Class Action ...
Share this article
About the Author
Recommended Reading
Leave a Reply
Log In
Read the latest articles and see your reports.
Popular Now
MDM Directories
Sign Up for the MDM Update Newsletter
The MDM update newsletter is your best source for news and trends in the wholesale distribution industry.